Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

2.9%

1 terminated out of 34 trials

Success Rate

92.3%

+5.7% vs benchmark

Late-Stage Pipeline

3%

1 trials in Phase 3/4

Results Transparency

0%

0 of 12 completed with results

Key Signals

92% success

Data Visualizations

Phase Distribution

27Total
Not Applicable (21)
Early P 1 (1)
P 1 (2)
P 2 (2)
P 4 (1)

Trial Status

Completed12
Recruiting12
Not Yet Recruiting5
Suspended1
Withdrawn1
Enrolling By Invitation1

Trial Success Rate

92.3%

Benchmark: 86.6%

Based on 12 completed trials

Clinical Trials (34)

Showing 20 of 20 trials
NCT07273604Not ApplicableCompletedPrimary

Psychological Interventions for Multiple Sclerosis: Effects on Anxiety, Depression, and Cognition.

NCT06884579Not ApplicableCompletedPrimary

Educational Programs Based on Healthy Habits to Improve Quality of Life and Psychosocial Profile in Women With Neurodegenerative Diseases: the ADVICE Protocol Study (Phase 2)

NCT04031469Suspended

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

NCT07789171Not ApplicableCompletedPrimary

Synbiotic Supplementation as a Part of Dietary Modification in Multiple Sclerosis

NCT07222956Phase 2Not Yet RecruitingPrimary

A Study of Remibrutinib Using MR Imaging in Relapsing or Progressive MS

NCT07758270RecruitingPrimary

Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.

NCT07501520Not ApplicableCompletedPrimary

Effect of Low Histamine-Based Modified Mediterranean Diet in Multiple Sclerosis

NCT06925022Not ApplicableCompletedPrimary

Educational Programs Based on Healthy Habits to Improve Quality of Life and Psychosocial Profile in Women With Neurodegenerative Diseases: The ADVICE Protocol Study (Phase 1)

NCT06864936Not ApplicableRecruitingPrimary

Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis

NCT06641271Not ApplicableEnrolling By InvitationPrimary

Study to Investigate Vagus Nerve Stimulation Paired With Motor Task for Remyelination and Functional Recovery

NCT07680738Not ApplicableCompleted

Transcranial Direct Current Stimulation for Fatigue, Mood, and Cognition in Multiple Sclerosis

NCT07006805Phase 1Withdrawn

RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple Sclerosis

NCT07292480Not ApplicableRecruitingPrimary

Monthly Monitoring of Plasma NfL in Treated Relapsing-remitting Multiple Sclerosis to Detect Persistent Infraclinical Disease Activity

NCT07645937Not ApplicableNot Yet RecruitingPrimary

Effects of Low-Load Blood Flow Restriction Exercise on Rectus Femoris Muscle Morphology in Individuals With Relapsing-Remitting Multiple Sclerosis

NCT07631923Not ApplicableNot Yet Recruiting

Acute Intermittent Hypoxia Combined With Gait Training in Multiple Sclerosis

NCT07624812Not ApplicableCompletedPrimary

Behavioral and Electrophysiological Evidence of the Modulation of Fatigue in RR-MS

NCT07589062Not ApplicableNot Yet RecruitingPrimary

Healthy Eating and Active Living for People Living With Multiple Sclerosis (HEAL MS): A Lifestyle Program for People With Multiple Sclerosis

NCT07230015Not ApplicableRecruitingPrimary

Combined Motor Imagery and Vestibular Rehab for MS

NCT07545889Not ApplicableNot Yet Recruiting

Multicenter Prospective Study Analyzing the Occurrence of Multiple Sclerosis Relapses Without Radiological Evidence: Myth or Reality?

NCT07225361Phase 4Recruiting

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

Scroll to load more

Research Network

Activity Timeline